lobaplatin
lobaplatin
A 1:1 diastereomeric mixture comprising of <i>R</i>,<i>R</i>,<i>S</i> and <i>S</i>,<i>S</i>,<i>S</i> configuration of platinum(II) complexes with 1,2-bis(aminomethyl)cyclobutane as the carrier ligand and lactate as the leaving group. It is a third-generation platinum anticancer drug approved in China for the treatment of chronic myelogenous leukaemia, inoperable metastatic breast cancer and small cell lung cancer.